Industry News

Latest orthopaedic industry news on orthopaedic companies, devices, implants & technology trends.

North America spinal implants market growing at CAGR 5.1% in the forecast period 2022 according to new research report Details WhaTech Channel: Medical Market Research Published: 06 December 2016 Submitted by Shubham DwivediWhaTech Pro News from Viewed: 0North America Spinal Implants Market, By Product Type (Fusion Implant Devices (Cervical Fusion (Anterior Cervical Fusion, Posterior Cervical Fusion), Thoraco-Lumbar Fusion (Anterior Thoraco-Lumbar Fusion, Posterior Thoraco-Lumbar Fusion, Interbody Thoraco-Lumbar Fusion)), Non-Fusion Implant Devices (Dynamic Stabilization Devices, Artificial Discs, Annulus Repair Devices, Nuclear Disc Prostheses), VCF Treatment Devices (Baloon Kyphoplasty Devices, Verteboplasty Devices)), By End-User (Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others), By Country (U.S.

Read more ...

Jurors in Texas awarded six California plaintiffs $1.041 billion in a lawsuit against Johnson & Johnson and its subsidiary, DePuy Orthopaedic, over defective hip implants. It's another ignominious defeat for J&J, who've been hit with six of the seven largest jury awards this year, according to the American Bar Association. It's also another in a long line of lawsuit losses for J&J and DePuy over their hip implants, which plaintiffs allege cause tissue death, bone erosion, and other injuries. Not So Hip The most recent jury verdict, which concerns DePuy's Pinnacle hip implants, is comprised of $32 million in compensatory damages, and the rest in punitive damages.

Read more ...

NEW YORK, Dec. 5, 2016 /PRNewswire/ -- Global biological implant market is anticipated to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus affecting industrial growth in the coming years.

Read more ...

Albany, NY -- (SBWIRE) -- 12/05/2016 -- Interspinous spacers sometimes also called as Interspinous process decompression systems, are the devices implanted between vertebral spinous processes. These spacers are made up of a very strong but lightweight metal (titanium) which is biocompatible in the human body. These devices are imbedded in body to confine painful motion else enabling normal motion and to treat lumbar spinal stenosis, discogenic low-back pain, facet syndrome, disc herniations, and non-traumatic instability. Lumbar spinal stenosis is a thinning of the spinal canal in the lower back which causes compression on nerves and it is developed gradually with age.

Read more ...

Dental Crown and Bridges Market: Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021 This press release was orginally distributed by SBWire Sarasota, FL -- (SBWIRE) -- 12/05/2016 -- Crowns and bridges are a treatment through which teeth conditions are repaired. In crown treatment, new teeth are implanted on the decaying or damaged tooth. In bridges treatment, a gap between teeth is filled by implanting a specific number of teeth in the gaps. The crowns and bridges are fixed onto existing teeth and can only be removed by a professional. These devices are usually made from the ceramic material but sometimes gold, silver or acrylic can also be used.

Read more ...

LONDON – Scientists are taking the battle to prevent HIV to the next level with large-scale trials set to start using injections to protect vulnerable groups such as gay men and women in Africa for at least two months. Further down the road, the hope is to produce matchstick-sized implants containing slow-release drugs - similar to existing under-the-skin contraceptive devices - that could offer year-long protection. Companies with drugs involved include GlaxoSmithKline, Gilead Sciences and Merck. The initiatives build on the success of Gilead's once-daily pill Truvada, which has proved remarkably effective at stopping HIV infection during sex.More on this.

Read more ...

Dallas, TX -- (ReleaseWire) -- 11/29/2016 --The global spinal implants and spinal devices market is expected to reach over USD 19.54 billion by 2024 according to a new report by Grand View Research, Inc. The key drivers of the market include the rising number of spinal injuries, increasing trend in the adoption of sedentary lifestyles, postural defects stemming from bad posture habits at work and while driving, and a large number of people suffering from obesity. In addition to the above, the introduction of the image-based spinal navigation technology, the evolution of titanium biologics, and the ongoing research on the genetically modified bone morphogenetic proteins are also expected to positively reinforce the market growth.

Read more ...

LONDON, Nov. 28, 2016 /PRNewswire/ -- 3D printed medical devices are state-of-the-art medical devices that involve a process of developing three dimensional solid objects from a digital model. Patient specific treatment is the main advantage of 3D printing technology in the healthcare industry. In the domain of healthcare, 3D printing technology is used to develop medical devices such as dental implants, orthopaedic implants, prosthetics, and hearing aids. Furthermore, hospitals and academic institutes use 3D printing technology to develop various models for training purposes. 3D printed medical devices considered in the report typically use technologies such as stereolithography (SLA), selective layer sintering (SLS), digital light processing (DLP), fused deposition modelling (FDM), polyjet / inkjet 3D printing, and electronic beam melting (EBM).

Read more ...

November 28, 2016 - By Dolores Ford Ronda Stryker Insider Sell The director of Stryker Corp, Ronda Stryker a few days ago got almost $1,352,716 USD for 12,000 shares in the Stryker Corp firm at an approx. $112.7 per every share. She also sold 114,000 shares valued at $12,910,550 USD in the last month. At the moment, Ronda Stryker has rights to a total of 23.99 million shares or 6.39% of the company’s market cap (total dollar market value of all company’s outstanding shares).

Read more ...

Dublin, Ireland-based Medtronicreported worldwide revenue of $7.3 billion in the second quarter of 2017, ended Oct. 28, 2016. The FDA cleared Belgrade, Mont.-based Xtant Medical's Xsert Lumbar Expandable Interbody System. Salt Lake City-based Amedica Corp. named Dana Lyons its new vice president of sales and marketing. Kalamazoo, Mich.-based Strykerbeat industry analysts and reported $1.39 earnings per share in the third quarter, an 11.2 percent year-over-year improvement. Warsaw, Ind.-based Zimmer Biomet introduced its Comprehensive Vault Reconstruction System. Atlanta-based Vertera Spine received an award for its COHERE Cervical Interbody Fusion Device. Lyon-Ecully, France-based Spineway's capital increased nearly $1.49 million on Nov.

Read more ...

Submit Community Content

If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!